![Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251409004924:20418078_t1_p139.jpg?idApp=UINPBA000064)
Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-26.jpg&id=643587)
These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or
![A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD | American Society of Nephrology A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/32/2/469/F1.large.jpg)
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD | American Society of Nephrology
![PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a43dfdedbb0b141c7477cec9b71802d834e22060/2-Table1-1.png)
PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar
![PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9dcc30c0903acb07ca0222d47923a2c4e79dfe42/2-Table1-1.png)
PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar
![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-2f.jpg&id=643587)